Category : Search result: Pharmaceutical companies India


India Pharma Targets $500B, Innovation Hub by 2047

India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.

Govt Audits 700+ Cough Syrup Makers, Tests 19 Samples

Indian government intensifies scrutiny on pharmaceutical sector, auditing 700+ cough syrup manufacturers. Health Ministry reveals 19 drug samples collected for testing amid child safety concerns. Read the full report.

2 Lakh+ Private Firms Closed in India in 5 Years

Government data reveals 2,04,268 private companies closed in India from 2020-21 to 2024-25. No employee rehabilitation plan exists. Read the full report on the corporate clean-up drive.

Mumbai bizwoman assaulted by pharma officials

A 51-year-old Mumbai businesswoman was held at gunpoint, stripped and threatened by pharmaceutical company executives. Mumbai Police registers case under multiple sections.

UP busts ₹150 crore pharma narcotics racket

Uttar Pradesh authorities uncover massive pharmaceutical diversion network smuggling codeine-based cough syrups as narcotics across 7 states and borders. 87 firms face FIRs in chilling organized crime operation.

NCB Issues Warrants in ₹600 Crore Drug Racket

NCB obtains non-bailable warrants against Digital Vision owners in massive ₹600 crore drug diversion case. Key accused involved in international pharmaceutical fraud uncovered in Himachal Pradesh.

India's Top 10 IT Companies by Market Cap in 2025

Discover the top 10 Indian IT companies by market cap in 2025. TCS leads the ranking with a massive Rs 11.25 lakh crore valuation, followed by Infosys and HCL Tech. Explore the list now!

Sudeep Pharma IPO Allotment Status Today

Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!

Sudeep Pharma IPO Subscribed 94 Times

Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.

Page 1 of 4